Key facts
- Clickbio’s last known valuation is $2.5M (Jan 2019).
- It has raised $860K; the latest was Later Stage VC in Jun 2025.
- Notable investors include Battle Born Venture, Ozmen Ventures, Reno Seed Advisors, Society for Laboratory Automation and Screening.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Clickbio
- ·The full record, as it builds
Funding rounds
No funding rounds for Clickbio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clickbio
Developer of laboratory products designed to offer customized labware. The company's products include sterile fill station tubing, magnetic particle separator, liquid waste station, and library prep tool, and to design and manufacture truly innovative labware that accelerates the pace of human discovery, enabling researchers to have application-specific labware that can be bought online.
- Sector
- Healthcare
- HQ
- Reno, NV, United States
- Founded
- 2015
- Employees
- 6
- Website
- clickbio.com/
- Ownership
- Privately Held (backing)
Clickbio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clickbio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clickbio in its N-PORT filings yet. We sweep new filings monthly.